Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
Cantor Fitzgerald
US Army
Accenture
Daiichi Sankyo

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,182,958

« Back to Dashboard

Which drugs does patent 7,182,958 protect, and when does it expire?

Patent 7,182,958 protects ADCIRCA and CIALIS and is included in two NDAs.

Protection for ADCIRCA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-two patent family members in twenty-eight countries.

Summary for Patent: 7,182,958
Title:.beta.-carboline pharmaceutical compositions
Abstract:Formulations containing a PDE5 inhibitor, a water-soluble diluent, a lubricant, a hydrophilic binder, a disintegrant, and optional microcrystalline cellulose and/or a wetting agent, and their use in treating sexual dysfunction, are disclosed.
Inventor(s): Oren; Peter L. (Fishers, IN), Anderson; Neil R. (West Lafayette, IN), Kral; Martha A. (Indianapolis, IN)
Assignee: Lilly Icos LLC. (Wilmington, DE)
Application Number:10/031,464
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,182,958
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,182,958
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 7,182,958

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eli Lilly Co ADCIRCA tadalafil TABLET;ORAL 022332-001 May 22, 2009 AB2 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Lilly CIALIS tadalafil TABLET;ORAL 021368-004 Jan 7, 2008 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Lilly CIALIS tadalafil TABLET;ORAL 021368-001 Nov 21, 2003 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,182,958

PCT Information
PCT FiledApril 26, 2000PCT Application Number:PCT/US00/11130
PCT Publication Date:February 08, 2001PCT Publication Number: WO01/08686

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Colorcon
Julphar
UBS
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.